Navigating the Risks of Compounded Versions of GLP-1 Drugs for Weight Loss
By Olde Del Mar Surgical In recent years, GLP-1 receptor agonists like semaglutide and tirzepatide have gained prominence for their effectiveness in managing type 2 diabetes and aiding weight loss. However, the surge in demand has led to the emergence of unapproved and compounded versions of these drugs, raising significant safety concerns. The U.S. Food…